Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$8.30B | 163.7x | 0.82 | A$24.84 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.6% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$3.38B | -20.7x | -1.67 | A$2.96 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -37.1% Downside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$1.33B | -44.3x | 0.49 | A$4.22 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$972.56M | -1.4x | 0.37 | A$0.79 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avita Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$596.69M | -1x | 0.09 | A$3.51 | -19.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.3% Upside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$592.59M | -13.2x | 0.45 | A$1.28 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$494.55M | -9.3x | -0.6 | A$0.34 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orthocell Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$340.98M | -39.7x | 3.97 | A$1.42 | 13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$334.68M | -2.1x | 0.01 | A$0.05 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | A$267.76M | -12.8x | -1.06 | A$0.50 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | A$231.04M | -16.1x | 0.49 | A$1.32 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$185.39M | -19.4x | -0.61 | A$0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$183.31M | 20.9x | 0.38 | A$1.06 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.2% Upside | Upgrade to Pro+ | |
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$164.23M | -2.3x | -0.65 | A$0.47 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$134.83M | -34x | 0.02 | A$0.80 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | A$96.16M | -3.8x | -0.39 | A$0.14 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | A$94.32M | -14.1x | -3.65 | A$0.71 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -31% Downside | Upgrade to Pro+ | |
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$80.70M | -15.1x | -0.79 | A$0.62 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | A$79.91M | -4.3x | 12.25 | A$0.03 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$54.06M | -4.3x | -0.1 | A$0.24 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | A$53.80M | -8.7x | -0.26 | A$0.05 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | A$53.30M | -5x | -0.16 | A$0.02 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$53.20M | -2x | -0.35 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$49.78M | -2.6x | -0.54 | A$0.04 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$49.18M | -3.4x | 0.01 | A$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$47.28M | -6.6x | -0.14 | A$0.11 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$40.27M | -5x | 0.77 | A$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | A$35.15M | -5x | -0.1 | A$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$29.11M | -3x | 0.26 | A$0.09 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$29.06M | -2.5x | -1.21 | A$0.17 | 7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.1% Downside | Upgrade to Pro+ |